BioELife Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LITH research report →
About the company
Engaged in the cannabinoid industry, BioELife Corp. provides a comprehensive selection of products. Their offerings span a variety of items such as adult gummies and tinctures (both available in combo formulations with chirorub), an intensive relief rub, standard tinctures, additional adult gummies, premium pre-rolled products, and flower.
- CEO
- Michael Terpin
- IPO
- 2009
- Employees
- 1
- HQ
- Seal Beach, CA, US
Price Chart
- Market Cap
- $941
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -3.75
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 170.28%
- ROIC
- 161.73%
- Revenue
- $0 · 0.00%
- Net Income
- $-336,958 · -36.42%
- EPS
- $-0.13 · -30.00%
- Op Income
- $-73,743
- FCF YoY
- 37.16%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.50
- Avg Volume
- 7
Get TickerSpark's AI analysis on LITH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LITH coverage
Recent articles, reports, and earnings notes.
No research on LITH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LITH report →Similar companies
Peers in the same neighborhood.